Future studies should focus on defining the roles of Tregs and immune checkpoints in COVID-19, especially focusing on T cells with potential tissue homing capabilities and defining the suppressive capabilities of CD62L+ Tregs in COVID-19. This evidence concerns the gene SELL and COVID-19.